The core activity of Proteomedix is the development and marketing of blood tests for the diagnosis of prostate cancer, in particular the product Proclarix, a non-invasive blood test that enables the identification of high-grade prostate cancer and serves as a complement to the PSA test.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Next generation blood test for prostate cancer; non-invasive reflex test for elevated PSA, provides a Proclarix Risk Score and supports biopsy decision-making.
Knowledge
No knowledge articles yet
Once Proteomedix AG has claimed this profile, we'll publish editorial articles and case studies here together.